Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hologic Inc (NQ: HOLX )

76.87 -0.60 (-0.77%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,094,084
Open 77.96
Bid (Size) 76.06 (2)
Ask (Size) 77.07 (3)
Prev. Close 77.47
Today's Range 76.28 - 77.96
52wk Range 67.59 - 84.67
Shares Outstanding 253,487,389
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hologic Presents New Research Demonstrating How Its Breast Imaging AI Solution Performs Similarly Across Diverse Populations
From Hologic, Inc.
Via Business Wire
Peering Into Hologic's Recent Short Interest
Via Benzinga

Performance

YTD
+6.09%
+6.09%
1 Month
-8.18%
-8.18%
3 Month
-5.82%
-5.82%
6 Month
+3.53%
+3.53%
1 Year
+10.99%
+10.99%

More News

Read More
Hologic Invites Attendees to Step Into the Future of Breast Health and AI at RSNA 2024
From Hologic, Inc.
Via Business Wire
Looking Into Hologic's Recent Short Interest
Via Benzinga
Assessing Hologic: Insights From 10 Financial Analysts
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Today
Via Benzinga
Critical Insights From Hologic Analyst Ratings: What You Need To Know
Via Benzinga
Hologic to Webcast Presentations at Upcoming Investor Conferences
From Hologic, Inc.
Via Business Wire
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024
From Hologic, Inc.
Via Business Wire
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
Via Benzinga
Here's How Much You Would Have Made Owning Hologic Stock In The Last 20 Years
Via Benzinga
Peering Into Hologic's Recent Short Interest
Via Benzinga
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Hologic Adds Gynesonics' Sonata System In $350M Acquisition To Boost Fibroid Treatments
Via Benzinga
Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health
From Hologic, Inc.
Via Business Wire
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024
From Hologic, Inc.
Via Business Wire
Here's How Much You Would Have Made Owning Hologic Stock In The Last 10 Years
Via Benzinga
Analyst Scoreboard: 8 Ratings For Hologic
Via Benzinga
Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month
From Hologic, Inc.
Via Business Wire
Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference
From Hologic, Inc.
Via Business Wire
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,200 Today
Via Benzinga
GE Aerospace To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Hologic Analysts Boost Their Forecasts After Q3 Results
Via Benzinga
The Analyst Verdict: Hologic In The Eyes Of 8 Experts
Via Benzinga
Tech Stocks Drop Ahead Of Key Earnings; Nvidia Falls, CrowdStrike Hits 8-Month Low: What's Driving Markets Tuesday?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.